Reports from Kangwon National University Highlight Recent Findings in COX-2 Inhibitors (Vismodegib Identified As a Novel Cox-2 Inhibitor Via Deep-learning-based Drug Repositioning and Molecular Docking Analysis).

Keywords for this news article include: Chunchon, South Korea, Asia, Antiinflammatory Agents, COX-2 Inhibitors, COX-2 Therapy, Cox-2 Inhibitor Therapy, Cyclooxygenase 2 Inhibitors, Cyclooxygenase Inhibitors, Drugs and Therapies, Health and Medicine, Pain Medicine, Pharmaceuticals, Kangwon National University. Keywords: Chunchon; South Korea; Asia; Antiinflammatory Agents; COX-2 Inhibitors; COX-2 Therapy; Cox-2 Inhibitor Therapy; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drugs and Therapies; Health and Medicine; Pain Medicine; Pharmaceuticals EN Chunchon South Korea Asia Antiinflammatory Agents COX-2 Inhibitors COX-2 Therapy Cox-2 Inhibitor Therapy Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors Drugs and Therapies Health and Medicine Pain Medicine Pharmaceuticals 1644 1644 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Current study results on Drugs and Therapies - COX-2 Inhibitors have been published. Chunchon, South Korea, Asia, Antiinflammatory Agents, COX-2 Inhibitors, COX-2 Therapy, Cox-2 Inhibitor Therapy, Cyclooxygenase Inhibitors, Drugs and Therapies, Health and Medicine, Pain Medicine, Pharmaceuticals, Cyclooxygenase 2 Inhibitors. [Extracted from the article]